Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricDGXQuest DiagnosticsLHLabcorpDVADaVita
Snapshot
Price$236.27$314.00$184.36
Market cap$23.88B$23.53B$15.08B
Valuation
P/E25.4x27.4x15.2x
Forward P/E22.1x21.1x14.2x
Growth
Revenue growth11.0%7.3%6.7%
EPS growth14.9%30.2%6.6%
Profitability
Net margin9.1%6.7%5.7%
ROE14.1%10.9%181.2%
Balance sheet & cash
Debt / equity0.82x0.66x77.99x
Free cash flow yield5.4%5.2%8.2%
Dividend yield1.7%1.1%—
Verdict
Investment ratingNeutral· 52Neutral· 52Neutral· 53

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearDGXtoday $236LHtoday $314DVAtoday $184
2027$203.57 – $298.57+26% CAGR$306.53 – $449.57+43% CAGR$147.41 – $216.20+17% CAGR
2028$233.86 – $343.00+20% CAGR$398.98 – $585.16+37% CAGR$157.15 – $230.49+12% CAGR
2029$268.66 – $394.03+19% CAGR$519.31 – $761.65+34% CAGR$167.54 – $245.73+10% CAGR
2030$308.64 – $452.67+18% CAGR$675.93 – $991.36+33% CAGR$178.62 – $261.97+9% CAGR
2031$354.56 – $520.02+17% CAGR$879.79 – $1,290.36+33% CAGR$190.42 – $279.29+9% CAGR
5-yr CAGR8.5% – 17.1%22.9% – 32.7%0.6% – 8.7%